1. Home
  2. ADMA vs GXO Comparison

ADMA vs GXO Comparison

Compare ADMA & GXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • GXO
  • Stock Information
  • Founded
  • ADMA 2004
  • GXO 2021
  • Country
  • ADMA United States
  • GXO United States
  • Employees
  • ADMA N/A
  • GXO N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • GXO Transportation Services
  • Sector
  • ADMA Health Care
  • GXO Consumer Discretionary
  • Exchange
  • ADMA Nasdaq
  • GXO Nasdaq
  • Market Cap
  • ADMA 5.1B
  • GXO 4.8B
  • IPO Year
  • ADMA N/A
  • GXO N/A
  • Fundamental
  • Price
  • ADMA $17.74
  • GXO $47.99
  • Analyst Decision
  • ADMA Strong Buy
  • GXO Buy
  • Analyst Count
  • ADMA 4
  • GXO 13
  • Target Price
  • ADMA $24.25
  • GXO $55.62
  • AVG Volume (30 Days)
  • ADMA 2.7M
  • GXO 1.1M
  • Earning Date
  • ADMA 08-07-2025
  • GXO 08-05-2025
  • Dividend Yield
  • ADMA N/A
  • GXO N/A
  • EPS Growth
  • ADMA N/A
  • GXO N/A
  • EPS
  • ADMA 0.84
  • GXO 0.62
  • Revenue
  • ADMA $459,381,000.00
  • GXO $12,230,000,000.00
  • Revenue This Year
  • ADMA $23.35
  • GXO $9.65
  • Revenue Next Year
  • ADMA $27.67
  • GXO $5.97
  • P/E Ratio
  • ADMA $21.27
  • GXO $76.88
  • Revenue Growth
  • ADMA 62.23
  • GXO 23.40
  • 52 Week Low
  • ADMA $10.21
  • GXO $30.46
  • 52 Week High
  • ADMA $25.67
  • GXO $63.33
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 32.83
  • GXO 75.30
  • Support Level
  • ADMA $20.42
  • GXO $42.49
  • Resistance Level
  • ADMA $22.37
  • GXO $44.02
  • Average True Range (ATR)
  • ADMA 0.88
  • GXO 1.18
  • MACD
  • ADMA -0.28
  • GXO 0.22
  • Stochastic Oscillator
  • ADMA 1.07
  • GXO 98.54

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About GXO GXO Logistics Inc.

GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.

Share on Social Networks: